288 related articles for article (PubMed ID: 29282796)
1. Disease-causing mutations in the promoter and enhancer of the ornithine transcarbamylase gene.
Jang YJ; LaBella AL; Feeney TP; Braverman N; Tuchman M; Morizono H; Ah Mew N; Caldovic L
Hum Mutat; 2018 Apr; 39(4):527-536. PubMed ID: 29282796
[TBL] [Abstract][Full Text] [Related]
2. Disruption of OTC promoter-enhancer interaction in a patient with symptoms of ornithine carbamoyltransferase deficiency.
Luksan O; Jirsa M; Eberova J; Minks J; Treslova H; Bouckova M; Storkanova G; Vlaskova H; Hrebicek M; Dvorakova L
Hum Mutat; 2010 Apr; 31(4):E1294-303. PubMed ID: 20127982
[TBL] [Abstract][Full Text] [Related]
3. A promoter variant in the OTC gene associated with late and variable age of onset hyperammonemia.
Han ST; Anderson KJ; Bjornsson HT; Longo N; Valle D
J Inherit Metab Dis; 2022 Jul; 45(4):710-718. PubMed ID: 35605046
[TBL] [Abstract][Full Text] [Related]
4. High-frequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (OTC) locus by oligonucleotide array CGH.
Shchelochkov OA; Li FY; Geraghty MT; Gallagher RC; Van Hove JL; Lichter-Konecki U; Fernhoff PM; Copeland S; Reimschisel T; Cederbaum S; Lee B; Chinault AC; Wong LJ
Mol Genet Metab; 2009 Mar; 96(3):97-105. PubMed ID: 19138872
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
[TBL] [Abstract][Full Text] [Related]
6. Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.
Caldovic L; Abdikarim I; Narain S; Tuchman M; Morizono H
J Genet Genomics; 2015 May; 42(5):181-94. PubMed ID: 26059767
[TBL] [Abstract][Full Text] [Related]
7. Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency.
Li S; Cai Y; Shi C; Liu M; Liu B; Lin L; Xiao X; Hao H
Med Sci Monit; 2018 Oct; 24():7431-7437. PubMed ID: 30333473
[TBL] [Abstract][Full Text] [Related]
8. OTC gene in ornithine transcarbamylase deficiency: clinical course and mutational spectrum in seven Korean patients.
Lee JH; Kim GH; Yoo HW; Cheon CK
Pediatr Neurol; 2014 Sep; 51(3):354-359.e1. PubMed ID: 25011434
[TBL] [Abstract][Full Text] [Related]
9. Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
Climent C; Rubio V
Hum Mutat; 2002 Feb; 19(2):185-6. PubMed ID: 11793483
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.
Arranz JA; Riudor E; Marco-Marín C; Rubio V
J Inherit Metab Dis; 2007 Apr; 30(2):217-26. PubMed ID: 17334707
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of ornithine transcarbamylase gene mutations in three boys affected with late-onset ornithine transcarbamylase deficiency].
Chen Z; Wen P; Wang G; Liu X; Chen L; Chen S; Wan L; Cui D; Shang Y; Li C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Oct; 31(5):565-9. PubMed ID: 25297582
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis in nine unrelated Italian patients affected by OTC deficiency: detection of novel mutations in the OTC gene.
Bisanzi S; Morrone A; Donati MA; Pasquini E; Spada M; Strisciuglio P; Parenti G; Parini R; Papadia F; Zammarchi E
Mol Genet Metab; 2002 Jun; 76(2):137-44. PubMed ID: 12083811
[TBL] [Abstract][Full Text] [Related]
13. An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective
Balestra D; Ferrarese M; Lombardi S; Ziliotto N; Branchini A; Petersen N; Bosma P; Pinotti M; van de Graaf SFJ
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228018
[No Abstract] [Full Text] [Related]
14. Exonic duplication of the OTC gene by a complex rearrangement that likely occurred via a replication-based mechanism: a case report.
Yokoi K; Nakajima Y; Inagaki H; Tsutsumi M; Ito T; Kurahashi H
BMC Med Genet; 2018 Dec; 19(1):210. PubMed ID: 30541480
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
[TBL] [Abstract][Full Text] [Related]
16. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene.
Yamaguchi S; Brailey LL; Morizono H; Bale AE; Tuchman M
Hum Mutat; 2006 Jul; 27(7):626-32. PubMed ID: 16786505
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.
Choi JH; Lee BH; Kim JH; Kim GH; Kim YM; Cho J; Cheon CK; Ko JM; Lee JH; Yoo HW
J Hum Genet; 2015 Sep; 60(9):501-7. PubMed ID: 25994866
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic analysis of five Chinese patients with urea cycle disorders.
Zheng Z; Lin Y; Lin W; Zhu L; Jiang M; Wang W; Fu Q
Mol Genet Genomic Med; 2020 Jul; 8(7):e1301. PubMed ID: 32410394
[TBL] [Abstract][Full Text] [Related]
19. In Silico Analysis of a De Novo OTC Variant as a Cause of Ornithine Transcarbamylase Deficiency.
Ozdemir Y; Cag M; Gul S; Yüksel Z; Ergoren MC
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):153-156. PubMed ID: 34670952
[TBL] [Abstract][Full Text] [Related]
20. Streamlined assessment of gene variants by high resolution melt profiling utilizing the ornithine transcarbamylase gene as a model system.
Dobrowolski SF; Ellingson CE; Caldovic L; Tuchman M
Hum Mutat; 2007 Nov; 28(11):1133-40. PubMed ID: 17565723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
